Nachrichten zur Pfizer Inc. Aktie

Pfizers Comeback Is Underway

…

GNW-News: Pfizer und BioNTech erhalten positive CHMP-Empfehlung für an LP.8.1 angepassten COVID-19-Impfstoff in der Europäischen Union

^* Daten zeigten, dass der an LP.8.1 angepasste COVID-19-Impfstoff verglichen mit den COVID-19-Impfstoffformulierungen 2024-2025 eine verbesserte …

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

NEW YORK and MAINZ, GERMANY, July 25, 2025 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”)…

Should You Forget Pfizer and Buy This Magnificent Dividend Stock Instead?

Key PointsPfizer stands as one of the largest pharmaceutical companies in the world.Although it has an attractive 7.1% yield, it…

AIM weekly movers: Oxford BioDynamics gains recognition from Pfizer trial

Oil and gas producer Empyrean Energy (LON: EME) says the operator of the Mako field has signed a gas sales…

Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount

The companies new effort would bypass traditional middlemen to cut the drugs monthly cost from a list price of around…

Bristol Myers, Pfizer to sell blood thinner Eliquis directly to patients By Reuters

Bristol Myers, Pfizer to sell blood thinner Eliquis directly to patients…

Bristol Myers, Pfizer to sell blood thinner Eliquis directly to patients

US drugmakers Bristol Myers and Pfizer said on Thursday that they will make their blood thinner, Eliquis, available directly to…

This Once-Dominant Healthcare Stock Down 50% Is Finally Ready for a Comeback

Key PointsPfizer’s earnings and stock price soared in early pandemic days thanks to its coronavirus treatment and vaccine.But waning demand…

AIM movers: Pfizer confirms efficacy of Oxford BioDynamics EpiSwitch and Sosandar write down reduces profit

Oxford BioDynamics (LON: OBD) says Pfizer has published information on its use of EpiSwitch biomarkers as a liquid biopsy in…

How Will Pfizers Oncology Drugs Perform in Q2 Earnings?

PFEs oncology unit is in focus ahead of Q2 results, with key drugs facing both rising demand and market pressure.…

Pfizer (PFE) Stock Sinks As Market Gains: Heres Why

Pfizer (PFE) concluded the recent trading session at $25.35, signifying a -1.17% move from its prior days close.…

Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?

Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

A Message to All Investors From Motley Fool CEO Tom Gardner

Motley Fool co-founder and CEO Tom Gardner gets candid on stock market fears, what new investors should avoid, stock market…

JNJ vs. Pfizer: Which Pharma Giant is the Better Investment Now?

JNJs growth outlook, rising estimates, and strength in Innovative Medicine give it an edge over Pfizer in 2025.…

Pfizer (PFE) Ascends While Market Falls: Some Facts to Note

Pfizer (PFE) closed at $25.62 in the latest trading session, marking a +1.51% move from the prior day.…

3 Disappointing Blue Chip Stocks That Have Crashed as Much as 87% in 10 Years

Key PointsThese stocks have all fallen between 19% and 87% over the past decade.Changing market conditions and consumer tastes and…

Pfizer Neutral

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer auf "Neutral" mit einem Kursziel von 30…

3 No-Brainer Stocks to Buy in July

Key PointsAbbVie offers something for every investor.Eli Lilly could be overdue for a big rally.Vertex Pharmaceuticals is in a new…

Warren Buffett Owns 9 Ultra-High-Yield Dividend Stocks. Heres the Best of the Bunch.

Key PointsBuffetts Berkshire Hathaway portfolio includes only one ultra-high-yield stock.However, his "secret portfolio" is loaded with ultra-high-yielders.The best of the…

The Best Dividend Stocks Id Buy Right Now

Key PointsEven Warren Buffett appreciates the power of dividend stocks. These companies sport meaningful payouts and promising prospects.See which ones…

2 Stocks to Buy With Less Than $50

Key PointsPfizer is slowly building a foundation that will help its business recover from recent headwinds.Encouraging developments on the clinical…

Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity

Key PointsWall Streets smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all downside…

Pfizer: Options Activity Speaks Bullish

…

Is Pfizer Stock a Yield Trap? @themotleyfool #stocks $PFE $NVS $BMY $BBIO

…

Pfizer (PFE) Outperforms Broader Market: What You Need to Know

In the latest trading session, Pfizer (PFE) closed at $25.32, marking a +1.12% move from the previous day.…

Pfizers Strong Late-Stage Pipeline Can Drive Long-Term Growth

PFEs robust late-stage pipeline, recent FDA wins and deep oncology bets position it for long-term growth through 2030.…

Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock

Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could…

Former Pfizer executive probed on alleged Covid vaccine delay

Former Pfizer executive probed on alleged Covid vaccine delay - CNN…

House committee subpoenas Pfizer executive in probe of alleged COVID vaccine delay, CNN reports By Reuters

House committee subpoenas Pfizer executive in probe of alleged COVID vaccine delay, CNN reports…

3 No-Brainer Stocks to Buy for Under $100 Right Now

Whats the biggest misconception about investing? The idea that you need a lot of money to get started is certainly…

Want to Collect $2,000 in Dividends Each Year? Heres How Much You Should Aim to Invest in the Stock Market Today.

You can generate a lot of recurring cash flow from the stock market without having to worry about selling your…

PFEs Hympavzi Phase III Hemophilia Study With Inhibitors Meets Goal

Pfizers Hympavzi meets key phase III goals, demonstrating a significant reduction in bleeding in hemophilia patients with inhibitors.…

Pfizer announces positive results for hemophilia treatment By Investing.com

Pfizer announces positive results for hemophilia treatment…

Pfizer Could Be The Turnaround Story In The Pharmaceutical Space

…

Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing

In the closing of the recent trading day, Pfizer (PFE) stood at $24.31, denoting a +1.17% move from the preceding…

Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?

PFE faces a decline in COVID revenues, LOE pressure and IRA impacts but rising EPS estimates offer a glimmer of…

My 5 Favorite Dirt Cheap Stocks to Buy Right Now

Though indexes have rebounded, the first half of the year has been rocky for investors. The market had to digest…

10 Stocks That Pay $100 or More in Dividends

Looking for stocks that pay $100 in annual income? Youve come to the right place. Even a small investment in…

Beyond Air (XAIR) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. DATETuesday, June 17, 2025, at 4:30 p.m. EDTCALL PARTICIPANTSChairman and Chief Executive Officer — Steven Adam…

Pfizer vs BMY: Which Oncology Drugmaker Is a Better Choice for Now?

Pfizers broader portfolio and higher dividend yield give it an edge over Bristol Myers in the oncology showdown.…

Pfizer: An Offensive Play For A Bear Market

…

2 Top Stocks to Buy With Less Than $30

Though wealthy and successful investors garner much attention on Wall Street, equity markets are accessible to the average person. Thats…

Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trumps plan

The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions…

Targeted cancer drugs may replace chemo for some patients — and drugmakers say theyre getting closer

Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve their…

Pfizer, AbbVie und Co unter Druck: Trump mit dem nächsten Hammer?

US-Präsident Donald Trump will der Pharma-Industrie weiter an den Kragen gehen. Laut Kreisen möchte der Republikaner die Pharmawerbung in den…

Pfizer, AbbVie und Co unter Druck: Trump mit dem nächsten Hammer?

US-Präsident Donald Trump will der Pharma-Industrie weiter an den Kragen gehen. Laut Kreisen möchte der Republikaner die Pharmawerbung in den…

Why I Just Bought More of This Beaten-Down 7%-Yielding Dividend Stock

Pick a time frame -- year to date, last 12 months, last three years, last five years, or last 10…

5 Large Drug Stocks That Are Poised to Ride on Sector Recovery

In the Large-Cap Pharmaceuticals industry, AbbVie, Novartis, Pfizer, Sanofi and Bayer are worth retaining amid macro pressure and rising innovation.…

Warren Buffett Says Buy This Index Fund, and Heres How It Could Turn $500 Per Month Into $1 Million

Warren Buffett is the CEO of the Berkshire Hathaway holding company, where he oversees a number of wholly owned subsidiaries…